» Authors » Francisco Cardoso

Francisco Cardoso

Explore the profile of Francisco Cardoso including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 174
Citations 1724
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cardoso F, Schmidt P
J Parkinsons Dis . 2025 Feb; :1877718X241308482. PMID: 39973501
This article reflects on two proposals to classify and stage Parkinson's disease (PD) and related conditions based on the presence of aggregated alpha-synuclein (ASN) detected by alpha-synuclein aggregation assay (SAA)....
2.
Vale T, Santos D, Oliveira D, Brandao P, Pereira D, Bouca-Machado R, et al.
Parkinsonism Relat Disord . 2025 Jan; 132:107276. PMID: 39848139
Background: The Movement Disorder Society Non-Motor Rating Scale (MDS-NMS) serves as a comprehensive clinical assessment tool for non-motor symptoms in Parkinson's disease (PD) OBJECTIVES: This study aims to validate the...
3.
Rezende L, Aguiar C, Balbino J, Maia D, Maciel R, Camargos S, et al.
Mov Disord Clin Pract . 2025 Jan; PMID: 39825747
No abstract available.
4.
Espay A, Lees A, Cardoso F, Frucht S, Erskine D, Sandoval I, et al.
Parkinsonism Relat Disord . 2025 Jan; 131():107256. PMID: 39794217
The α-synuclein seed amplification assay (αSyn-SAA) sensitively detects Lewy pathology, the amyloid state of α-synuclein, in the cerebrospinal fluid (CSF) of patients with Parkinson's disease (PD). The αSyn-SAA harnesses the...
5.
de Oliveira P, Rodolpho Ramalho S, Martins B, Cardoso F
Parkinsonism Relat Disord . 2025 Jan; 131():107258. PMID: 39793322
Background: Parkinson's disease (PD) is characterized by motor and non-motor features. There are several proposed clinical markers to define disease severity. However, if rapid eye movement sleep behavior disorder (RBD)...
6.
Soares T, Vale T, Guedes L, Maciel R, Antunes A, Camargos S, et al.
Mov Disord Clin Pract . 2024 Oct; 12(1):34-42. PMID: 39460979
Background: The MDS-UPDRS has been available in English since 2008, showing satisfactory clinimetric results and being proposed as the new official benchmark scale for Parkinson's disease (PD), being cited as...
7.
Kalia L, Berg D, Kordower J, Shannon K, Taylor J, Cardoso F, et al.
Mov Disord . 2024 Sep; 39(10):1710-1715. PMID: 39250594
No abstract available.
8.
Brandao P, Pereira D, Grippe T, de Carvalho Bispo D, Maluf F, Titze-de-Almeida R, et al.
Front Neuroanat . 2024 Aug; 18:1362165. PMID: 39206076
Background: The Parkinson's Disease-Cognitive Rating Scale (PD-CRS) is a widely used tool for detecting mild cognitive impairment (MCI) in Parkinson's Disease (PD) patients, however, the neuroanatomical underpinnings of this test's...
9.
Cardoso F
Mov Disord Clin Pract . 2024 May; 11 Suppl 3:S39-S41. PMID: 38812083
No abstract available.
10.
Grippe T, Shamli-Oghli Y, Darmani G, Nankoo J, Raies N, Sarica C, et al.
Mov Disord . 2024 May; 39(8):1364-1374. PMID: 38787806
Background: Low-intensity transcranial ultrasound stimulation (TUS) is a noninvasive brain stimulation (NIBS) technique with high spatial specificity. Previous studies showed that TUS delivered in a theta burst pattern (tbTUS) increased...